Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × OTHER × Olfaction Disorders × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3439 Neoplasms 2702 Prostatic Neoplasms 1563 Colorectal Neoplasms 1232 Lung Neoplasms 1156 Motor Activity 750 Head and Neck Neoplasms 610 Pancreatic Neoplasms 593 Colonic Neoplasms 580 Uterine Cervical Neoplasms 550 Carcinoma, Non-Small-Cell Lung 550 Carcinoma, Hepatocellular 549 Rectal Neoplasms 510 Stomach Neoplasms 478 Brain Neoplasms 428 Anxiety Disorders 394 Ovarian Neoplasms 391 Pain 369 Esophageal Neoplasms 343 Neoplasm Metastasis 338 Polycystic Ovary Syndrome 335 Fatigue 316 Urinary Bladder Neoplasms 312 Precursor Cell Lymphoblastic Leukemia-Lymphoma 301 Melanoma 295 Depression 281 Multiple Myeloma 277 Endometrial Neoplasms 258 Lymphoma 257 Hematologic Neoplasms 248

Interventions

Docosahexaenoic Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02529332 2018-08-21

Omega-3 Supplementation for Smell Dysfunction

Stanford University

Phase NA Completed

Olfaction Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡